|
Randolph JF, Scarlett JM, Stokol T, Saunders KM, MacLeod JN: Expression,
bioactivity, and clinical assessment of recombinant feline erythropoietin. Am J Vet
Res 2004; 65:1355-1366.
Randolph JF, Scarlett JM, Stokol T, MacLeod JN: Clinical safety and efficacy of
recombinant canine erythropoietin in dogs with the anemia of chronic renal failure
and dogs with recombinant human erythropoietin induced red cell aplasia. J Vet Int
Med 2004; 18:81-91.
Randolph JF, Stokol T, Scarlett JM, Saunders KM, MacLeod JN: Comparison of
the biologic activity and safety of recombinant canine erythropoietin with that of
recombinant human erythropoietin in clinically normal dogs. Am J Vet Res 1999;
60:636-642.
Randolph JF, Toomey J, Center SA, Scarlett JM, Reimers T, Graham
P, Nachrenier R: Use of the urine cortisol -to- creatinine ratio for monitoring
dogs with pituitary-dependent hyperadrenocorticism during induction of
teatment withmitotane(o,p-DDD). Am J Vet Res, 59:258-261, 1998.
|
